Combined effect of oxidative stress-related gene polymorphisms on atherosclerosis

Biochemical and Biophysical Research Communications

Volumn 379, Issue 4, 2009, Pages 861-865

  Katakami, N ^a   Sakamoto, K ^a   Kaneto, H ^a   Matsuhisa, M ^a   Shimizu, I ^b,c   Ishibashi, F ^d   Osonoi, T ^e   Kashiwagi, A ^f   Kawamori, R ^g   Hori, M ^a   Yamasaki, Y ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c Ehime Prefectural Imabari Hospital   (Japan)

^d Ishibashi Clinic   (Japan)

^e Naka Memorial Clinic   (Japan)

^f SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^g JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Diabetes; IMT; Oxidative stress; Polymorphism

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; BIOLOGICAL MARKER; GLUTAMATE CYSTEINE LIGASE; MYELOPEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; AGED; ALLELE; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL;

ALLELES; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE-CYSTEINE LIGASE; HUMANS; MALE; OXIDATIVE STRESS; PEROXIDASE; POLYMORPHISM, GENETIC; TUNICA INTIMA;

EID: 58949093982     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.12.154     Document Type: Article

References (22)

1. West I.C. Radicals in oxidative stress in diabetes. Diabet. Med. 17 (2002) 171-180
2. Meister A., and Anderson M.E. Glutathione. Annu. Rev. Biochem. 52 (1983) 711-760
3. Minova H.R., and Mulcahy R.T. An electrophile responsive element (EpRE) regulates gannma-naphthoflavone induction of the human gannma-glutamylcysteine synthetase regulatory subunit gene. J. Biol. Chem. 273 (1998) 14683-14689
4. Nakamura S., Kugiyama K., Sugiyama S., Miyamoto S., Koide S., Fukushima H., Honda O., Yoshimura M., and Ogawa H. Polymorphism in the 5′-flanking region of human Glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction. Circulation 105 (2002) 2968-2973
5. Daugherty A., Dunn J.L., Rateri D.L., and Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94 (1994) 437-444
6. Piedrafita F.J., Molander R.B., Vansant G., Orlova E.A., Pfhal M., and Reynolds W.F. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem. 271 (1996) 14412-14420
7. Reynolds W.F., Chang E., Douer D., Ball E.D., and Kanda V. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood 90 (1997) 2730-2737
8. Aviram M., Hardak E., Vaya J., Mahmood S., Milo S., Hoffman A., Billicke S., Draganov D., and Rosenblat S. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 101 (2000) 2510-2517
9. Humbert R., Adler D.A., Disteche C.M., Hassett C., Omiecinski C.J., and Furlong C.E. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3 (1993) 73-76
10. Bhattacharyya T., Nicholls S.J., Topol E.J., Zhang R., Yang X., Schmitt D., Fu X., Shao M., Brennan D.M., Ellis S.G., Allayee H., Lusis A.J., and Hazen S.L. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 299 (2008) 1265-1276
11. Kuremoto K., Watanabe Y., Ohmura H., Shimada K., Mokuno H., and Daida H. R/R genotype of human paraoxonase (PON1) is more protective against lipoprotein oxidation and coronary artery disease in Japanese subjects. J. Atheroscler. Thromb. 10 (2003) 85-92
12. Azumi H., Inoue N., Takeshita S., Rikitake Y., Kawashima S., Hayashi Y., Itoh H., and Yokoyama M. Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation 100 (1999) 1494-1498
13. Guzik T.J., West N.E., Black E., McDonald D., Ratnatunga C., Pillai R., and Channon K.M. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 102 (2000) 1744-1747
14. Yamasaki Y., Kawamori R., Matsushima H., Nishizawa H., Kodama M., Kajimoto Y., Morishima T., and Kamada T. Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes 43 (1994) 634-639
15. Malin R., Rantalaiho V., Huang X.H., Wirta O., Pasternack A., Leinonen J.S., Alho H., Jokela H., Koivula T., Tanaka T., Okada K., Ochi H., Toyokuni S., and Lehtimaki T. Association between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects. Hum. Genet. 105 (1999) 179-180
16. Yamada Y., Izawa H., Ichihara S., Takatsu F., Ishihara H., Hirayama H., Sone T., Tanaka M., and Yokota M. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl. J. Med. 347 (2002) 1916-1923
17. Inoue N., Kawashima S., Kanazawa K., Yamada S., Akita H., and Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22phox gene in patients with coronary artery disease. Circulation 97 (1998) 135-137
18. Cahilly C., Ballantyne C.M., Lim D.S., Gotto A., and Marian A.J. A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ. Res. 86 (2000) 391-395
19. Nikpoor B., Turecki G., Fournier C., Theroux P., and Rouleau G.A. A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am. Heart J. 142 (2001) 336-339
20. Makela R., Loimaala A., Nenonen A., Mercuri M., Vuori I., Huhtala H., Oja P., Bond G., Koivula T., and Lehtimaki T. The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes. Clin. Biochem. 41 (2008) 532-553
21. Mackness M., and Mackness B. Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?. Free Radic. Biol. Med. 37 (2004) 1317-1323
22. Ng C.J., Shih D.M., Hama S.Y., Villa N., Navab M., and Reddy S.T. The paraoxonase gene family and atherosclerosis. Free Radic. Biol. Med. 38 (2005) 153-163